Interpretation of long-term overall survival from the PRODIGE 23 study. Letter to the Editor regarding “Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial”, by T. Conroy et al.
医学
结直肠癌
新辅助治疗
放化疗
肿瘤科
内科学
总体生存率
癌症
乳腺癌
作者
Roberto Moretto,Guglielmo Vetere,Marco Di Maio
出处
期刊:Annals of Oncology [Elsevier] 日期:2024-08-28卷期号:35 (11): 1063-1064被引量:2